Camurati-Engelmann disease in conjunction with hypogonadism

Endocrine Practice

Volumn 11, Issue 6, 2005, Pages 399-407

  Gupta, Shaili ^a   Cheikh, Issam E ^a  

^a UNION MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ARTICLE; BASAL METABOLIC RATE; BLOOD; BLOOD CELL COUNT; CAMURATI ENGELMANN SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; HUMAN; HYPOGONADISM; LIVER FUNCTION TEST; MALE; MIDDLE AGED; RADIOGRAPHY; TESTIS; THORAX RADIOGRAPHY; ULTRASTRUCTURE; URINE;

BASAL METABOLISM; BLOOD CELL COUNT; CAMURATI-ENGELMANN SYNDROME; HORMONES; HUMANS; HYPOGONADISM; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; TESTIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750696311     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.6.399     Document Type: Article

References (36)

1. Vanhoenacker FM, Janssens K, Van Hul W, Gershoni-Baruch R, Brik R, De Schepper AM. Camurati-Engelmann disease: review of radioclinical features. Acta Radiol. 2003;44:430-434.
2. Cockayne EA. Case for diagnosis. Proc R Soc Med. 1920; 13:132-136.
3. Camurati M. Di un raro caso di osteite simmetrica ereditaria degli arti inferiori. Chir Organi Mov. 1922;6:662-665.
4. Engelmann G. Ein Fall von Osteopathia hyperostotica (sclerotisans) multiplex infantilis. Forschr Gebiete Rontgenstr Nuklearmed. 1929;39:1101-1106.
5. Neuhauser EB, Schwachman H, Wittenborg M, Cohen J. Progressive diaphyseal dysplasia. Radiology. 1948;51:11-22.
6. Saraiva JM. Progressive diaphyseal dysplasia: a three-generation family with markedly variable expressivity. Am J Med Genet. 1997;71:348-352.
7. Sparkes RS, Graham CB. Camurati-Engelmann disease: genetics and clinical manifestations with a review of the literature. J Med Genet. 1972;9:73-85.
8. Naveh Y, Kaftori JK, Alon U, Ben-David J, Berant M. Progressive diaphyseal dysplasia: genetics and clinical and radiological manifestations. Pediatrics. 1984;74:399-405.
9. Kumar B, Murphy WA, Whyte MP. Progressive diaphyseal dysplasia (Engelmann disease): scintigraphic-radiographic-clinical correlations. Radiology. 1981;140:87-92.
10. Ramon Y, Buchner A. Camurati-Engelmann's disease affecting the jaws. Oral Surg Oral Med Oral Pathol. 1966;22:592-599.
11. Wright M, Miller NR, McFadzean RM, et al. Papilloedema, a complication of progressive diaphyseal dysplasia: a series of three case reports. Br J Ophthalmol. 1998;82:1042-1048.
12. Grey AC, Wallace R, Crone M. Engelmann's disease: a 45-year follow-up. J Bone Joint Surg Br. 1996;78:488-491.
13. Brat HG, Hamoir X, Matthijs P, Lambin P, Van Campenhoudt M. Camurati-Engelmann disease: a late and sporadic case with metaphyseal involvement. Eur Radiol. 1999;9:159-162.
14. Campos-Xavier B, Saraiva JM, Savarirayan R, et al. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet. 2001;109:653-658.
15. Smith R, Walton RJ, Corner BD, Gordon IR. Clinical and biochemical studies in Engelmann's disease (progressive diaphyseal dysplasia). Q J Med. 1977;182:273-294.
16. Kaftori JK, Kleinhaus MD, Naveh Y. Progressive diaphyseal dysplasia (Camurati-Engelmann): radiographic follow-up and CT findings. Radiology. 1987;164:777-782.
17. Verbruggen LA, Bossuyt A, Schreuer R, Somers G. Clinical and scintigraphic evaluation of corticosteroid treatment in a case of progressive diaphyseal dysplasia. J Rheumatol. 1985;12:809-813.
18. Naveh Y, Alon U, Kaftori JK, Berant M. Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy. Pediatrics. 1985;75:321-323.
19. Inaoka T, Shuke N, Sato J, et al. Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease). Clin Nucl Med. 2001;26:680-682.
20. Janssens K, Gershoni-Baruch R, Van Hul E, et al. Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13. J Med Genet. 2000;37:245-249.
21. Ghadami M, Makita Y, Yoshida K, et al. Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3. Am J Hum Genet. 2000;66:143-147.
22. Fujii D, Brissenden JE, Derynck R, Francke U. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 1986;12:281-288.
23. Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone. 1998;23:87-93.
24. Hock JM, Canalis E, Centrella M. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology. 1990;126:421-426.
25. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell. 1998;9:1903-1918.
26. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93-97.
27. Saito T, Kinoshita A, Yoshiura KI, et al. Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1. J Biol Chem. 2001;276:11469-11472.
28. Gnessi L, Fabbri A, Spera G. Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev. 1997;18:541-609.
29. Schlatt S, Meinhardt A, Nieschlag E. Paracrine regulation of cellular interactions in the testis: factors in search of a function. Eur J Endocrinol. 1997;137:107-117.
30. Godin I, Wylie CC. TGF beta 1 inhibits proliferation and has a chemotropic effect on mouse primordial germ cells in culture. Development. 1991;113:1451-1457.
31. Avallet O, Vigier M, Perrard-Sapori MH, Saez JM. Transforming growth factor beta inhibits Leydig cell functions. Biochem Biophys Res Commun. 1987;146:575-581.
32. Fauser BC, Hsueh AJ. Effect of transforming growth factor-beta on human chorionic gonadotropin induced testosterone production by cultured rat testicular cells. Life Sci. 1988;43:1363-1370.
33. Morera AM, Cochet C, Keramidas M, Chauvin MA, de Peretti E, Benahmed M. Direct regulating effects of transforming growth factor beta on the Leydig cell steroidogenesis in primary culture. J Steroid Biochem. 1988;30:443-447.
34. Teerds KJ, Dorrington JH. Localization of transforming growth factor beta 1 and beta 2 during testicular development in the rat. Biol Reprod. 1993;48:40-45.
35. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995;92:2572-2576.
36. Damestoy A, Perrard MH, Vigier M, Sabido O, Durand P. Transforming growth factor beta-1 decreases the yield of the second meiotic division of rat pachytene spermatocytes in vitro. Reprod Biol Endocrinol. 2005;3:22. Available at: http://www.rbej.com/content/pdf/1477-7827-3-22.pdf. Accessed for verification August 11, 2005.